Brief: Ensysce Biosciences On June 13 Regained Compliance With Equity Requirement In Nasdaq Listing Rule
June 14 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES - ON JUNE 13 NOTIFIED BY NASDAQ THAT
COMPANY
HAS REGAINED COMPLIANCE WITH EQUITY REQUIREMENT IN NASDAQ
LISTING RULE 5550(B)(10
Source text for Eikon: ID:
Further company coverage: ENSC.O
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing